Development of a Specific Anti-capsid Antibody- and Magnetic Bead-Based Immunoassay to Detect Human Norovirus Particles in Stool Samples and Spiked Mussels via Flow Cytometry. by Razafimahefa, Ravo Michèle et al.
Vol.:(0123456789) 
Food and Environmental Virology 
https://doi.org/10.1007/s12560-021-09494-w
ORIGINAL PAPER
Development of a Specific Anti‑capsid Antibody‑ and Magnetic 
Bead‑Based Immunoassay to Detect Human Norovirus Particles 
in Stool Samples and Spiked Mussels via Flow Cytometry
Ravo M. Razafimahefa1 · Louisa F. Ludwig‑Begall1 · Mamadou Amadou Diallo2 · Benjamin G. Dewals2 · 
Alain Vanderplasschen2 · Olivier Nivelles2 · Caroline Deketelaere2 · Axel Mauroy3 · Etienne Thiry1 
Received: 27 April 2021 / Accepted: 28 July 2021 
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
Abstract
Human noroviruses impose a considerable health burden globally. Here, a flow cytometry approach designed for their detec-
tion in biological waste and food samples was developed using antibody-coated magnetic beads. Antipeptide antibodies 
against murine norovirus and various human norovirus genotypes were generated for capture and coated onto magnetic beads. 
A flow cytometry assay was then implemented to detect bead-bound human norovirus GI.3 in patient stool samples and in 
norovirus-spiked mussel digestive tissues. The detection limit for stool samples was  105 gc/mL, thus bettering detection limits 
of commercially available norovirus diagnosis quick kits of 100-fold; the detection limit in spiked mussels however was ten-
fold higher than in stool samples. Further assays showed a decrease in fluorescence intensity for heat- or UV-inactivated virus 
particles. Overall, we demonstrate the application of a flow cytometry approach for direct detection of small non-enveloped 
virus particles such as noroviruses. An adaptation of the technology to routine diagnostics has the potential to contribute a 
rapid and sensitive tool to norovirus outbreak investigations. Further improvements to the method, notably decreasing the 
detection limit of the approach, may allow the analysis of naturally contaminated food and environmental samples.
Graphic Abstract
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Introduction
Noroviruses (NoVs) were first identified in Norwalk, Ohio 
(United States of America) in 1968 as the cause of epi-
demic gastroenteritis in an elementary school (Kapikian 
et al., 1972). Four years later, identification was carried 
out by electron microscopy analyses of infectious stool 
filtrates from affected persons during the outbreak. NoVs 
are now recognised as one of the major global causes of 
gastrointestinal illness and the major cause of viral food-
borne illness; their rapid detection is incremental to out-
break control (Glass et al., 2009; Mead et al., 1999). Noro-
viruses belong to Caliciviridae family of non-enveloped, 
positive-sense, single-stranded RNA viruses (Dolin et al., 
1972). Norovirus RNA is 7.5 to 7.7 kbp in length and con-
sists of three open reading frames (ORFs) (Lambden et al., 
1993). ORF1 encodes six non-structural proteins, from the 
N terminus to C terminus: p48, nucleoside-triphosphatase 
(NTPase), p22, VPg, 3C-like protease (3CLpro) and the 
RNA-dependent RNA polymerase (RdRp) (Hardy, 2005). 
ORF2 and ORF3 encode the major (VP1) and minor (VP2) 
capsid proteins, respectively (Jiang et  al., 1992). VP1 
is further divided into two major hinge-linked S and P 
domains, both of which are recognised by NoV antibodies 
(Li et al., 2009, 2010; Mallory et al., 2019; Parra et al., 
2013; Yoda et al., 2003). The S domain (residues 1 to 
217), demonstrated to be the most conserved VP1 region 
(Prasad et al., 1999), is responsible for capsid assembly. 
The C-terminal P domain (residues 226 to 530), composed 
of subdomain P1 and hypervariable subdomain P2 (resi-
dues 275 to 405), forms arch-like structures extending 
from the shell (Prasad et al., 1999); P2 has an important 
role in immune recognition and receptor interaction (Tan 
et al., 2008). Several monoclonal antibodies (mAbs) tar-
geting epitopes in the inner shell or S domain have been 
shown to be broadly reactive across different human and 
animal norovirus strains (Li et al., 2009, 2010; Parra et al., 
2013; Yoda et al., 2003). Li et al. (2009) previously gener-
ated three mAbs from a 60 kDa full-length recombinant 
capsid protein of norovirus GII.4 expressed in Escherichia 
coli; of these, the broadly cross-reactive mAb N2C3 tar-
geted the conserved epitope WIRNNF (six residues of the 
S domain; position 55–60). Parra et al. (2013) described 
mAb TV20, a broadly cross-reactive mAb generated from 
GII.3 HuNoV VLPs that recognises an epitope of five resi-
dues of the S domain (IDPWI; 52–56).
The mutations and frequent recombination of NoVs 
create high genetic variability (Ludwig-Begall et  al., 
2018), which poses a major problem for the production 
of cross-reactive vaccines and for efficient NoV detec-
tion with broadly reactive antibodies. Noroviruses are 
divided into ten genogroups according to the sequence 
homology of VP1 (Chhabra et al., 2019). GI, GII, GIV, 
GVIII and GIX viruses infect humans. These genogroups 
are subdivided into genotypes: GI (n = 9), GII (n = 27), 
GIV (n = 2), GVIII (n = 1) and GIX (n = 1) (Chhabra et al., 
2019). GII.4-related strains are the most prevalent strains 
worldwide and cause pandemics (Atmar & Estes, 2006; 
Siebenga et al., 2009). Recently, the emergence of a new 
epidemic strain, recombinant GII.4 Sydney (GII.P16-GII.4 
Sydney), was highlighted (Ruis et al., 2017).
The flow cytometer is a well-known instrument typi-
cally employed to characterise individual cells or to ana-
lyse sub-micron particles (Fuller & Sweedler, 1996; Tracy 
et al., 2010; Vorauer-Uhl et al., 2000). The main constraint 
of flow cytometry in its application to the study of viruses 
is their small size, which limits individual examination. 
However, certain viruses below the typical detection limits 
of flow cytometry analyses in size have been successfully 
identified when labelled with fluorescent dyes; amongst 
these are Cucumber Mosaic Virus (29 nm) (Iannelli, 1996; 
Iannelli et al., 1997), influenza virus (80 to 120 nm) (Yan 
et al., 2004, 2005), dengue virus (40 to 60 nm) (Zicari et al., 
2016) and human rotavirus (80 nm) (Gozalbo-Rovira et al., 
2021). The detection of virus particles via flow cytometry 
analysis is commonly based on fluorescence, this in con-
junction with various methods such as virus detection with 
antibodies directed against surface antigens (antibodies cou-
pled to beads) (Arakelyan et al., 2013; Iannelli et al., 1997; 
Kim et al., 2009; Yan et al., 2004, 2005; Yang et al., 2008), 
envelope labelling (Arakelyan et al., 2013; Tang et al., 2016; 
Zicari et al., 2016) and genetic material labelling (Brussaard 
et al., 2000; El Bilali et al., 2017; Loret et al., 2012). Cur-
rently, detection and quantification of NoVs is commonly 
performed by RT-qPCR (ISO 15216–1 2017). First steps 
towards NoV detection via flow cytometry were recently 
performed by Madrigal and Jones who used virus-specific 
antibodies to quantify virus-like particle binding to gram-
negative and gram-positive commensal bacteria (Madrigal 
& Jones, 2020).
NoV detection via flow cytometry based on magnetic 
beads requires suitable antibodies for capture and detection. 
Here, we generated rabbit antipeptide antibodies against 
an 18-mer peptide containing two previously mentioned 
epitopes (IDPWI and WIRNNF) in the S domain (Li et al., 
2009; Parra et al., 2013) with different levels of reactivity 
towards eight NoVs, including murine norovirus (MNV) and 
human norovirus (HuNoV). The amino acid alignment of 
the 18-mer peptide with representative GI and GII HuNoV 
genotypes and GV MVN1 is presented in Fig. 1. The anti-
peptide antibodies were coated onto magnetic beads for NoV 
capture. Bound NoV particles were then detected using a 
biotinylated mouse antibody and labelled with streptavidin 
conjugated to a fluorescent dye (Fig. 2). This approach was 
applied both to the detection of HuNoV in biological sam-
ples (faecal suspension) and in spiked food samples (mussel 
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Fig. 1  Sequence alignment 
of the 18-mer peptide with 
representatives of GI and GII 
HuNoVs and GV MNV1. Bold 
type residues of the peptide rep-
resent the epitopes 52IDPWI56 
and 55WIRNNF60. Those 
residues that are shared between 
both epitopes are represented 
by a dash
Fig. 2  Schematic representation 
of the flow cytometry approach. 
A Addition of samples to the 
antibody-coupled magnetic 
beads and binding of viruses to 
capture antibodies. B Bind-
ing detection by biotinylated 
monoclonal antibody directed 
against NoV. C Addition of 
PE-Cy5 conjugated streptavidin 
for fluorescent tagging of bound 
viruses. D Detection with flow 
cytometer instrument
 Food and Environmental Virology
1 3
digestive tissues (DTs)), where the coated magnetic beads 
served to isolate virus particles from a more complex matrix.
Materials and Methods
Ethics Statement
Animal experiments and the production of anti-peptide anti-
bodies were approved by the Animal ethics commission of 
Liège University (protocol number 1598).
Viruses and Cells
Cell Culture
RAW 264.7 (ATCC TIB-71) cells were grown at 37 °C 
with 5% of  CO2 in Dulbecco’s Minimal Essential Medium 
(DMEM), supplemented with 10% foetal calf serum, 2% 
of penicillin (10,000 units/mL)—streptomycin (50 mg/
mL) (Invitrogen), 1% of non-essential amino acids and 1% 
HEPES buffer (pH 7.6) (Invitrogen).
Viruses
MNV isolate MNV-1 CW1 (Thackray et al., 2007) was 
propagated in RAW 264.7 cells (starting MOI 0.05; 3-day 
incubation). For virus purification, flasks were first subjected 
to three freeze–thaw cycles. To remove cell debris, cultured 
MNV suspensions were centrifuged at 4000 ×g for 10 min 
at 4 °C. Supernatants were transferred to a new tube and a 
5 mL sucrose cushion (30% w/v in PBS) was layered under 
each supernatant prior to ultracentrifugation 23,000 ×g for 
1.5 h at 4 °C. The supernatants were discarded and pellets 
were suspended in PBS and kept at − 80 °C until use.
Faecal specimens testing positive for HuNoV were 
obtained from Dr Pascale Huynen (Centre Hospitalier Uni-
versitaire, Liège, Belgium) and Dr Katelijne Dierick (Scien-
sano, NRL for the diagnosis of HuNoV infections, Brussels, 
Belgium) (Table 1). Stool samples were diluted in PBS (to 
obtain 10% w/v preparation), briefly vortexed and centri-
fuged twice at 1500 ×g for 10 min and once at 5000 ×g for 
10 min. The supernatant was stored at − 80 °C until use.
Titration of Viruses (TCID50 assay)
Infectivity of MNV-1 CW1 was determined via  TCID50 
assay. Briefly, RAW 264.7 cells were seeded in a 96-well 
plate at a concentration of 4.104 cells per well. Plates 
were incubated at 37 °C with 5%  CO2 for at least 2 h 
before infection to allow cells to attach. Serial tenfold 
virus dilutions were prepared and added to the wells. 
After three days of incubation at 37 °C with 5%  CO2, 
plates were examined under the microscope and wells 
showing cells with cytopathic effects (CPE) for each 
dilution were counted. The Reed and Muench (1938) 
method was applied to express the infectivity as  TCID50/
mL. Each sample was analysed three times for technical 
replicates.
Inactivation Treatments
For heat inactivation, sealed tubes with 400–500 µL of 
HuNoV suspension were immersed in a 90 °C hot water 
bath for 2 min and were directly cooled on ice.
For UV-inactivation, 400–500 µL aliquots of HuNoV 
suspension in transparent 1.5 ml Eppendorf tubes were 
irradiated for 1  h with an R-52 Grid Lamp (UVP), 
which emits a uniform 254 nm high-intensity UV source 
(200–250 V, 50/60 Hz, 45 AMPS).
Artificial Contamination of Mussel DTs by Spiking
Fresh mussels (Mytilus edulis) were purchased at a local 
fish shop. Mussels were directly dissected upon arrival at 
the laboratory. The adductor muscle was first cut to open 
the mussels’; digestive tissues were then removed and kept 
at − 80 °C before spiking or analysis. For artificial con-
tamination, 1 g of DTs was spiked with heat- or UV-inacti-
vated or non-inactivated HuNoV GI.3. Non-spiked mussel 
DTs were included as negative controls. The spiked mussel 
DTs were homogenised using a TissueLyser (Qiagen) with 
a stainless-steel bead (5 mm) at 30 Hz for 2 min. Superna-
tants were recovered after centrifugation at 3000 ×g 5 min 
and 5000 ×g 10 min. To determine the LoD in mussel DTs, 
tenfold serial dilutions of HuNoV GI.3 were performed in 
mussel DT homogenates.









GII GII.4 Sydney 18.27
GI GI.3 17
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RT‑qPCR Analyses
RNA was extracted from 100 µL purified viral suspension 
using the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, 
CA, USA) and implementing the spin protocol as per the 
manufacturer’s instructions. The nucleic acid was eluted into 
50 µL elution buffer and stored at − 20 °C for subsequent 
analysis.
Primers and probes for the individual quantification of 
GI and GII NoVs by RT-qPCR were designed by the CEN/
TC/WG6/TAG4 research group (Loisy et al., 2005; Svraka 
et al., 2007). An overview of the primer and probe sequences 
is shown in Table 2. All primers and probes were purchased 
from IDT (Belgium).
The RT-qPCR one-step reaction was performed with an 
RNA Ultrasense™ one-step quantitative RT-PCR system 
(Invitrogen) in a 25 µL reaction volume containing 5 µL 
RNA template, 0.2 µM each of both forward and reverse 
primers and the probe (Table 2).
The cycling conditions were as follows: 55 °C for 15 min, 
95 °C for 1 min, and 40 cycles of 95 °C for 15 s, 60 °C 
for 30 s and 65 °C for 40 s. The RT-qPCR was performed 
using a CFX96 Touch™ Real-Time PCR Detection System 
(Bio-Rad). The standard curves for the molecular detec-
tion of GI NoV were constructed using plasmids containing 
primer–probe binding sites. Briefly, HuNoV GI ORF1/ORF2 
nucleotides 5321 to 5340 were cloned into a pGMT easy 
vector (Promega). Following transformation into Escheri-
chia coli DH5α, clones were screened, and in vitro tran-
scription of positive clones was performed with linearised 
plasmid samples using the HiScribe T7 Quick High Yield 
RNA Synthesis Kit (BioLabs). After DNase treatment, 
in vitro transcribed RNA was purified and quantified using 
the Quant-iT™ RiboGreen™ RNA Assay Kit (Invitrogen).
Reagents
Monoclonal mouse-antibodies L34D (ref. MA5-18241, 
Thermofisher) and S57S (ref. MA5-18237, Thermofisher) 
were used as detection antibodies for HuNoV GII and 
GI, respectively. Both mAbs have been tested by west-
ern blot, ELISA and lateral flow analysis according to the 
manufacturer.
Carboxyl magnetic beads between 5 and 5.9 µm in diam-
eter (mean size: 5.72 µm) were used (Spherotech, Liberty-
Ville, IL). 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Production and Purification of Antipeptide Antibodies
Two S domain epitopes, IDPWI and WIRNNF, identified 
by Parra et al. (2013) and Li et al. (2010), respectively, 
were selected since monoclonal antibodies targeting these 
epitopes have been shown to be broadly reactive; in addition, 
the S domain is known as a conserved region in the NoV 
capsid. A peptide encompassing 18 amino acids (VNMID-
PWIRNNFVQAPQG) of the NoV capsid protein contain-
ing these two epitopes was synthetised and conjugated with 
a immunogen keyhole limpet haemocyanin (KLH) carrier 
by Eurogentec (Liège, Belgium). Two rabbits were injected 
four times over a 12-week time period. The rabbits were 
first immunised intraperitoneally with 1 mg of peptide-KLH 
in an equal volume of Freund’s complete adjuvant (prim-
ing). Fourteen days later, they were boosted with 0.5 mg of 
peptide-KLH in an equal volume of Freund’s incomplete 
adjuvant; this was performed twice at 14-day intervals. Next, 
the sera were collected from immunised rabbits and were 
assayed for antibody production against the immunising 
Table 2  Oligonucleotide primer and probe sequences used to detect viruses belonging to human norovirus genogroups I and II (GI and GII) via 
real-time TaqMan RT-PCR
Primer and probe sequences (5′ → 3′) Product length (in base pairs, bp) (Position) Final concentra-
tion (nM)
HuNoV GI
 QNIF4: CGC TGG ATGCGNTTC CAT (F) 86 (5291–5376) 200
 NV1LCR: CCT TAG ACG CCA TCA TCA TTTAC (R) 200
 NV1LCpr: FAM-TGG ACA GGA GAY CGC RAT CT-BHQ (p) (5321–5340) 200
Sequence and positions based on the sequence of Norwalk virus 8FIIa strain (GenBank accession no. M87661.1) (where N is A, C, G, or T and 
Y is C or T and R is A or G) (Le Guyader et al., 2009)
HuNoV GII
 QNIF2: ATG TTC AGR TGG ATG AGR TTC TCW GA (F) 89 (5012–5100) 200
 COG2R: TCG ACG CCA TCT TCA TTC ACA (R) 200
 QNIFs: FAM-AGC ACG TGG GAG GGC GAT CG-BHQ (p) (5042–5061) 200
Sequence and positions based on the sequence of GII.4 Houston strain (GenBank accession number EU310927) (where R is A or G and W is 
A or T) (Le Guyader et al., 2009)
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antigens in an ELISA assay. Seropositive rabbits were given 
a final boost immunisation prior to a final bleeding.
Both R2 and R12 sera were purified with Protein A 
(Pierce™ Protein A Agarose, ref. 20334) using Pierce Spin 
Columns and elution buffer from the Pierce™ Co-Immuno-
precipitation Kit (ref. 26149, Invitrogen), following manu-
facturer’s instructions. The IgG antibodies were desalted 
on PD MidiTrap™ G-25 Sample Preparation Columns (GE 
Healthcare) and were suspended in PBS before measure-
ment of antibody concentrations against purified R2 and R12 
antipeptides with the Pierce™ BCA Protein Assay Kit (ref. 
23225).
Indirect ELISA Assay
The indirect ELISA assay was performed as described by 
Kolawole et al., (2014) with some modifications as fol-
lows. Briefly, an ELISA plate was coated overnight at 4 °C 
with 0.020 mg/mL of MNV-CW1 and HuNoV (previously 
purified via ultracentrifugation over a sucrose cushion as 
described above) in coating buffer (carbonate buffer pH 
9.6). For negative controls, wells were coated with coating 
buffer only. After washing with 0.15 M NaCl PBS-Tween 
0.05%, the plate was blocked for 1.5 h at 37 °C with 3% 
bovine serum albumin (BSA) in coating buffer. The plate 
was washed and diluted antipeptide antibodies (10 µg/mL) in 
ELISA buffer were added. After 1.5 h of incubation, plates 
were washed again and 100 µL of 1:1000 polyclonal goat 
anti-rabbit–horseradish peroxidase (HRP) (Invitrogen) was 
added. The plates were incubated for 2 h and then washed 
seven times before addition of 100 µL substrate 2,2’-Azino-
bis 3-thylbenzthiazoline sulfonic acid (ABTS), for 30 min. 
Plates were read at 405 nm on an iMark Microplate reader 
(EnSpire Plate reader).
Sandwich ELISA Assay
Ninety-six-well plates were coated with 5 µg/mL R2 anti-
peptide antibodies diluted in coating buffer and were left 
overnight at 4 °C; for negative controls, wells were coated 
with coating buffer only. Each well was blocked with 3% 
BSA in coating buffer for 1.5 h at 37 °C, and then the plates 
were washed three times with 0.15 M NaCl PBS-Tween 
0.05%. Ten-fold diluted GI.3 or GII.4 or GII.14 in ELISA 
buffer was added, and the plates were incubated for 1.5 h at 
37 °C. 1:20 ELISA buffer–diluted monoclonal anti-GI NoV 
antibody S57S or 1:20 diluted monoclonal antibody (mAb) 
L34D–anti-GII NoV was added and incubated for 1.5 h at 
37 °C. After washing, 1:1000 diluted secondary polyclonal 
rabbit anti-mouse–HRP (Dako) was added and incubated 
for 2 h. Plates were washed seven times and the ABTS rea-
gent was added. The signal was detected by measurement 
of optical density at 405 nm on an iMark Microplate reader 
(EnSpire Plate reader).
Immunofluorescence Assay
RAW 247.6 cells were plated on 18 mm glass coverslips 
in 12-well plates and grown overnight. At a confluency of 
70%, cells were infected with MNV1-CW1 at a MOI of 0.1. 
Twenty hours later, cells were fixed in 4% (v/v) paraform-
aldehyde in PBS for 25 min. After washing with PBS, sam-
ples were permeabilised in PBS containing 0.1% (v/v) Triton 
X-100 at room temperature for 15 min. Immunofluorescent 
staining (incubation and washes) was performed in PBS con-
taining 10% FCS (v/v) and 0.1% BSA. Antipeptide antibod-
ies were used as the primary antibody at dilution 1:500 (R2 
sera) and 1:200 (R12 sera) for 1 h at room temperature, fol-
lowed by Alexa Fluor 488 goat anti-mouse immunoglobulin 
G (H + L) (Invitrogen) as the secondary antibody (1:1000 
dilution). After washing, cells were mounted using Prolong 
Gold antifade reagent with Di Aminido Phenyl lndol (DAPI) 
(Invitrogen). Samples were analysed by confocal micros-
copy, using a Leica SP5 confocal microscope and compiled 
using ImageJ Software (Schindelin et al., 2012).
Coupling Antibodies to Beads
Coupling consisted of coating magnetic beads with R2 
antipeptide antibodies.  107 beads were activated in 500 µL 
of activation buffer (10 mM sodium acetate in deionized 
water pH 5) with 10 µL and 33 µL of N-hydroxysuccin-
imide (NHS 50 mg/mL) and N-(3-Dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC 100 mg/mL), 
respectively. NHS and EDC were used to prepare and acti-
vate amine-reactive esters of the carboxylate group to enable 
chemical binding. After a 20 min incubation at room tem-
perature, EDC/NHS were eliminated under magnet separa-
tion. Beads were washed once with activation buffer and 
were resuspended in 500 µL of the same buffer. Then, 50 µg 
of R2 antipeptide antibodies was mixed with the beads on 
a shaker for 3.5 h to form R2 antipeptide antibody–beads. 
Subsequently, the coupled beads were washed twice and 
resuspended in storage buffer (PBS 1% BSA and 0.05% of 
sodium azide) at a concentration of 2.104 microspheres/µL 
for storage.
The efficiency of coupling was tested by adding diluted 
(1:200) goat anti-rabbit Alexa fluor 488 into a tube con-
taining 2.104 mAb-coupled beads. After a 30 min incuba-
tion at 37 °C, beads were washed once with washing buffer 
(PBS 0.05% Tween 20), resuspended in 300µL PBS and 
analysed on a BD LSR Fortessa X-20 flow cytometer (BD 
Biosciences). Fluorescence emission was collected through 
530/30 (FITC) bandpass filters.
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Biotinylation of Detection Monoclonal Antibodies
For detection antibody biotinylation, 1 mL of 10 mM EZ-
Link™ NHS-SS-Biotin (Thermofisher) in DMSO was pre-
pared in a first step. Next, the appropriate volume of biotin was 
added to S57S mAbs and the mixture was incubated at room 
temperature for 1 h prior to purification using a Zeba Desalt 
Spin Column (Thermofisher) to remove the unreacted biotin. 
The newly biotinylated S57S mAbs were then stored at 4 °C.
Microsphere‑Based Assay
One hundred µL of virus suspension was incubated with 
2–4 ×  103 antibody-coupled beads for 1 h at room tem-
perature on a rocker. Virus-antibody–bead complexes were 
washed once with 200 µL of washing buffer and resuspended 
in 50 µL of incubation buffer beads (PBS 1% BSA and 0.2% 
Tween 20) and 1 µL of biotinylated detection antibodies 
diluted in incubation buffer and were then incubated for 1 h 
at room temperature on a rocker. To eliminate excess free 
detection antibodies, the complexes were washed twice. 
Then, diluted PE-Cy5-conjugated streptavidin was added 
and incubated for 1 h at room temperature on a rocker. 
Before analysis, free PE-Cy5-conjugated streptavidin was 
discarded in two wash steps and the labelled complex was 
resuspended in 300 µL of PBS. A filtered PBS sample was 
included in each experiment as negative control (background 
event recognition). All the experiments were performed in 
triplicate. Samples were analysed on a BD LSR Fortessa 
X-20 flow cytometer (BD Biosciences). Fluorescence emis-
sion was collected through 670/30 (PE-Cy5) bandpass fil-
ters. The data were processed with FlowJo, version V10.4.
Statistical Analyses
Statistical analyses were carried out using the R version 
3.6.3 software. The normality of the data was tested using 
a Shapiro–Wilk test. Student’s t test was used to evaluate 
differences between mean fluorescence intensity of samples 
and the negative control. A one-way ANOVA was applied 
to estimate whether differences between mean fluorescence 
intensity were significant. A P value less than 0.05 was con-
sidered significant.
Results
Characterisation of R2 and R12 Antipeptide 
Antibodies Against Murine Norovirus and Human 
Norovirus
Sera were characterised after rabbit immunisation with 
the 18 amino acid-large S domain peptide coupled to the 
KLH carrier. MNV-1 CW1-infected RAW264.7 cells were 
detected by immunofluorescence using both R2 and R12 
sera (Fig. 3A). Subsequently, both sera were purified and 
their cross-reactivity was demonstrated through an indirect 
ELISA assay wherein plates were coated with MNV iso-
late MNV-1 CW1 or HuNoV strains of different genotypes 
from stool samples (purified by ultracentrifugation to avoid 
competition between stool impurities and viral proteins). 
Both antipeptide antibodies were shown to have a higher 
affinity with MNV-1 CW1 when compared with different 
HuNoV genotypes. R2 antipeptide antibodies demonstrated 
reactivity against more HuNoV genotypes (GII.1, GII.2, 
GII.4, GII.14, GI.2 and GI.3) compared with R12 antipep-
tide antibodies, which did not react against HuNoV GII.1 
and GII.2 (Fig. 3B).
Immunoassay to Detect Human Norovirus
Preliminary experiments mimicking the magnetic bead-
based assay followed by flow cytometry were performed 
via a sandwich ELISA to detect HuNoV GI.3, GII.4 and 
GII.14. A weak positive signal was observed for GI.3 and 
GII.14 (Fig. 4). GII.4 detection, hitherto associated with a 
positive indirect ELISA result (Fig. 3B), was unsuccessful 
via the sandwich ELISA assay, this inconsistency indicating 
mAb L34D to be unsuited to GII.4 detection.
Norovirus Detection by Flow Cytometry 
Implementing a Magnetic Bead‑Based 
Immunoassay
Magnetic beads were first coated and saturated with R2 or 
R12 capture antipeptide antibodies to avoid non-specific 
reactions and false-positive signals, and beads were satu-
rated from 20 µg of capture antibody concentration (Fig. 5). 
Magnetic beads coated with 50 µg R2 antipeptide antibodies 
were used for the magnetic bead-based assay. The magnetic 
bead-based immunoassay in conjunction with flow cytom-
etry was performed on HuNoV GI.3 faecal suspension. The 
highest mean fluorescence intensity (MFI) for GI.3 detection 
was 838 (± 117) associated with 1.108 gc/mL; the fluores-
cence intensity decreased progressively with dilution, until 
reaching the detection limit of 15 (± 1.4) MFI which corre-
sponded to 5.105 gc/mL in faecal suspension (Fig. 6A). For 
all tested dilutions, quantification of immunocaptured virus 
genome from faecal suspension showed genome copy values 
to be lesser than those in faecal suspension (Fig. 6A). Bead-
bound virus particle concentrations were reduced gradually 
with dilution of the virus suspension (Fig. 6A). As previ-
ously reported (Razafimahefa et al., 2021), high temperatures 
(90 °C, 2 min) and prolonged exposure to UV light (1 h) 
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Fig. 3  R2 and R12 antipeptide antibodies cross-react with murine 
norovirus (MNV-1 CW1) and human noroviruses (HuNoVs) from 
different genotypes. A Reactivity of R2 (1:500) and R12 (1:200) sera 
against MNV infected RAW264.7 cells as determined by immuno-
fluorescence. Pre-immune sera (1:100) were used as negative con-
trols. B Cross-reactivity of purified R2 and R12 antipeptide antibod-
ies (10  µg/mL) against MNV-1 CW1 and purified HuNoVs from 
two genogroups (GI, GII) and different genotypes as determined by 
indirect ELISA assay. The dashed line represents the mean absorb-
ance values for the negative controls and indicates the threshold for a 
positive signal
Fig. 4  Detection of GI.3, GII.4 and GII.14 human norovirus 
(HuNoV) in stool samples (dilution 1:10) by sandwich ELISA assay 
using the broadly reactive R2 and R12 antipeptide antibodies as cap-
ture antibodies and specific monoclonal antibodies S57S for GI and 
L34D for GII (5 µg/mL) as detection antibodies. The dashed line rep-
resents the mean absorbance values for the negative controls and indi-
cates the threshold for a positive signal
Fig. 5  Mean fluorescence intensity depending on the saturation of 
magnetic beads with different quantities of R2 or R12 antipeptide 
antibodies
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are known to inactivate MNV particles. Here, subsequent to 
inactivating heat- or UV-treatment, HuNoV GI.3 remained 
detectable in faecal suspensions via molecular methods (RT-
qPCR) and flow cytometry assay, whilst fluorescence intensi-
ties as measured by flow cytometry decreased significantly 
for both inactivation treatments (Fig. 6B).
For GI.3 detection in mussel DTs, the MFI at 5.106 gc/mL 
was 965 (± 70) (Fig. 7A); whilst this value was higher than 
the highest recorded faecal suspension MFI, the virus genome 
concentration was 1.5  log10 higher in the faecal suspension 
(Fig. 6A). As the detection limit of GI.3 increased to 2.106 gc/
mL in mussel DTs (Fig. 7A), the background simultaneously 
increased. Both curves of virus genome concentrations from 
spiked mussels and immunocapture of virus from spiked mus-
sels intersect: the magnetic beads coated with R2 antipeptide 
antibodies showed a concentration effect when virus concen-
trations were under  105 gc/mL. After spiking of mussel DTs 
with infectious or inactivated GI.3, the signal was positive for 
all samples, whilst a significant reduction of the fluorescence 
intensity was remarked for inactivated GI.3 (as in faecal sus-
pensions) treatments (Fig. 7B). At the same time, genome 
copy values also decreased in spiked DTs. The concentra-
tion effect of R2 antibody-coated beads was also observed for 
inactivated GI.3, when RNA copies were under  105 gc/mL.
Fig. 6  GI.3 human norovirus (HuNoV) detection in faecal suspen-
sion by flow cytometry (histogram and mean of fluorescence intensity 
(MFI)). A Detection of different dilutions of GI.3 HuNoV in faeces 
and comparison between the quantification of genomic copies in fae-
cal suspension or after immunocapture. The limit of detection (LoD) 
was the genome copy quantity of the dilution corresponding to the 
last significant dilution compared with the negative control after flow 
cytometry analysis. B Detection of non-inactivated, heat-inactivated 
(90 °C, 2 min) and UV-inactivated (1 h) GI.3 HuNoV and compari-
son between the quantification of genomic copies in faecal suspen-
sion or after immunocapture. The threshold value for virus detection 
by flow cytometry was the value of the negative control: PBS. Gat-
ing controls are shown in Figure S1 and S2. Statistical significance: 
*p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001
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The gating strategies employed during the flow cytometry 
analyses for each experiment are shown in four supplementary 
figures (Figure S1–S4). Each plot shows the position of the gate 
for the starting population (i.e. the bead population); this frac-
tion of events is expressed as a percentage of the total events, 
where an event corresponds to the detection of a single bead. 
All virus-bead populations were considered for the histograms 
and the calculation of the mean fluorescence intensity (MFI).
Discussion
Ranging in size from 27 to 38 nm in diameter, NoV parti-
cles are significantly below the typical 300–500 nm detec-
tion limits for common flow cytometry instruments (Steen, 
2004). This study contributes meaningfully to the develop-
ment of a flow cytometry approach to detect HuNoVs in 
the context of routine detection, allowing for analysis of 
multiple samples per day and yielding immediate results 
regarding potential viral contamination. Firstly, we gener-
ated broadly reactive antipeptide antibodies against the S 
domain of the viral capsid protein. Secondly, we developed 
a magnetic bead-based immunoassay where magnetic beads 
were coated and saturated with the newly generated antipep-
tide antibodies. Finally, we utilised an adapted bead-based 
assay in a flow cytometry approach aimed at HuNoV GI.3 
detection in stool and spiked food samples.
The S domain is an ideal target for the production of 
broadly reactive anti-NoV antibodies due to its high con-
servation across NoV genogroups (Prasad et  al., 1999; 
Fig. 7  Detection of GI.3 human norovirus (HuNoV) in mussel diges-
tive tissues (DTs) by flow cytometry (histogram and mean of fluo-
rescence intensity (MFI)). A Detection by flow cytometry of GI.3 
HuNoV diluted in mussel DTs supernatants and comparison between 
the quantification of genomic copies in faecal suspension or after 
immunocapture. The limit of detection (LoD) was the genome copy 
quantity of the dilution corresponding to the last significant dilu-
tion compared with negative control after flow cytometry analysis. 
B Detection of non-inactivated, heat-inactivated (90  °C, 2 min) and 
UV-inactivated (1  h) GI.3 HuNoV spiked in mussel DTs and com-
parison between genomic copies quantification in faecal suspension 
or after immunocapture. The threshold value for virus detection by 
flow cytometry was the value of negative control: negative mussel 
DTs supernatant. Gating controls are shown in Figure S3 and S4. Sta-
tistical significance: *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001
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Vongpunsawad et al., 2013). Both epitopes contained in the 
peptides are the residues IDPWI and WIRNNF. All mAbs 
recognising these epitopes (previously produced from virus-
like particles (VLPs) or recombinant NoV capsid protein) 
have been shown to be broadly reactive (Li et al., 2009; 
Parra et al., 2013). Most cross-reactive mAbs that recog-
nise various NoV genogroups have been reported to target 
the S domain and P1 domain (Crawford et al., 2015; Hans-
man et al., 2012; Huang et al., 2014; Li et al., 2009; Parker 
et al., 2005; Parra et al., 2013; Zheng et al., 2018). However, 
since the S domain is localised at the capsid interior, parts 
of it can be less accessible to antibodies. The P domain has 
recently been shown to support two conformations (Smith & 
Smith, 2019), namely the rising conformation as evidenced 
in MNV (Katpally et al., 2008), HuNoV GII.10 (Hansman 
et al., 2012) and GII.4 (Devant et al., 2019), where the P 
domain rises from the S domain surface, and the resting 
conformation as represented by GI.1 (Prasad et al., 1999) 
and GII.2 viruses (Jung et al., 2019), where the P domain 
rests upon the S domain. Moreover, dynamic conforma-
tional changes have been reported for MNV and HuNoV 
GII.3; whilst the MNV conformational changes have been 
reported in response to aqueous conditions (the P domain 
rises from the S domain surface in solutions with higher pH 
and rests in solutions with lower pH (Song et al., 2020)), the 
mechanism is yet unclear for GII.3 viruses. The accessibil-
ity of S domain epitopes may be inferred from the dynamic 
rotation of the P domain. Interestingly, the antipeptide anti-
body developed against the S domain was shown to be reac-
tive against MNV-1 CW1 and to a lesser extent to several 
HuNoV strains in stool samples (GII.4, GII.14, GII.1, GII.2, 
GI.3 and GI.2) by an indirect ELISA.
The characterisation of antipeptide antibody R2 was also 
performed with a sandwich ELISA. This experiment mim-
ics the magnetic bead-based immunoassay in its setup. Our 
results suggest that broadly reactive antipeptide antibody R2 
is suitable for NoV capture being able to detect intact NoV 
particles. The mAb N2C3 that targets residues WIRNNF has 
previously been reported to be able to detect native HuNoV 
in stool samples (Li et al., 2009). In an effort to develop a 
flow cytometry approach for HuNoV detection in varying 
samples, we implemented magnetic beads coated with R2 
antipeptide antibodies. Virus detection by flow cytometry 
is typically based on fluorescence such as using fluorescent 
antibodies directed against surface antigens to detect viruses. 
Therefore, the high specificity and affinity of antibodies 
towards their antigens is required. Herein, the high affin-
ity between biotin and streptavidin was instrumentalised for 
the purpose of labelling. Our magnetic bead-based immu-
noassay in conjunction with flow cytometry, as tested both 
on biological waste and spiked food matrices, can detect 
HuNoVs in different samples. We showed that fluorescence 
intensity varies with the virus particle concentrations in 
both matrices. The detection limit of our flow cytometry 
approach as applied to stool samples was  105 gc/mL, render-
ing it more sensitive than the commercial rapid test currently 
utilised for HuNoV detection in biological samples, which 
presents a detection limit of  107 to  108 copies/mL (Khamrin 
et al., 2015; Ushijima et al., 2017). Importantly, this reduced 
LoD has the potential to allow detection at the lower end 
of the reported range of typical faecal shedding (patients 
may excrete from  105 to  1011 virus particles per gram of 
stool (Atmar et al., 2008)); this approach may thus provide 
a powerful tool for HuNoV diagnosis in clinical laboratory 
settings.
At  106 gc/mL, the LoD for HuNoV GI.3 in spiked mussel 
DTs was elevated. Since the concentration of HuNoVs in 
aquatic environments can range from 50 to  106 gc/L (Has-
sard et al., 2017) and in shellfish from  102 to  104 gc/g of DT 
(Stals et al., 2012), further optimisation of the approach is 
required to enhance the sensitivity of the method in its appli-
cation to food and environmental samples. We suggest that 
a high affinity between epitopes and antibodies (capture and 
detection) will be amongst the key determinants for future 
improvement of the approach, based on our observations 
that a stronger biotin–streptavidin interaction has already 
proven more efficacious than weak antibody–secondary anti-
body interactions for detection and staining. In this context, 
the identification of more accessible P1 and P2 subdomain 
epitopes for the generation of capture antibodies and the 
identification of specific epitopes for individual genogroups 
for the production of antipeptide detection antibodies may 
lead to an important improvement. Moreover, synthetic pep-
tides are a rapid and useful tool to produce broadly reactive 
anti-norovirus antibodies after identifying a conservative 
site. In the case of complex matrices such as shellfish, the 
virus elution and concentration step from the complex sam-
ples is also a critical step to be considered for further detec-
tion limit optimisation of the flow cytometry assay in mus-
sels. The advantage of using antipeptide antibodies coupled 
to magnetic beads is that this method not only allows for 
detection of virus particles during flow cytometry analysis 
but also permits an immunoconcentration and purification 
by removing traces of debris from complex matrices such as 
food samples and biological samples.
Using short peptides (18-mer peptide) for immunisa-
tion involves the generation of antipeptide antibodies that 
recognise linear epitopes. Here, we demonstrate that such 
antipeptide antibodies can bind native HuNoV in stool sam-
ples; we suggest that the epitopes in question are probably 
located on the surface of the folded S domain and are thus 
exposed. Detection of inactivated HuNoVs coincides with a 
notable decrease of fluorescence intensity; we attribute the 
observed signal decrease associated with inactivated viruses 
to conformational changes of the capsid surface which may 
have served to “hide” underlying epitopes, rendering them 
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inaccessible for capture with antipeptide antibodies. Since 
the epitopes correspond to only a small portion of the capsid, 
the alteration of this portion itself is unknown. Continued 
capture of inactivated HuNoVs by R2 antipeptide antibody-
coated magnetic beads was also confirmed via genome quan-
tification. Virus inactivation treatments can cause capsid 
damage and can lead to the genome release (Razafimahefa 
et al., 2021). Here, the antibodies used to capture and detect 
virus via flow cytometry can only recognise a small portion 
of the capsid, namely short, targeted epitopes. We suggest 
that these epitopes are still recognised by antibodies even 
though the genome is released. Since a positive flow cytom-
etry signal is thus not necessarily indicative of an “intact” 
virus (capsid enclosing a genome), RT-qPCR should be per-
formed for genome quantification.
Whilst flow cytometry has previously been applied to the 
detection of viruses in general, and recently to NoV VLPs in 
particular through binding to commensal bacteria (Madrigal 
& Jones, 2020), this study provides the first report on direct 
detection of viable HuNoVs via the magnetic bead-based 
immunoassay in conjunction with flow cytometry approach 
and thus serves as a proof-of-concept regarding the feasi-
bility of NoV detection via flow cytometry. The method 
may further provide information regarding remaining intact 
structural motives of detected viruses; future improvements 
will thus include not only the identification of more easily 
accessible (conserved) P1 or P2 subdomain peptides but also 
an investigation into the link between particle detection and 
determination of virus infectivity.
Conclusion
Antipeptide antibodies coupled to magnetic beads were 
able to capture MNV and diverse HuNoV particles. A 
magnetic bead-based immunoassay followed by flow 
cytometry analysis was capable of detecting HuNoVs in 
biological waste and food samples. The usefulness of our 
flow cytometry approach was proven in biological waste 
samples; the approach will be easily optimisable for appli-
cation to food and environmental samples. Immunomag-
netic capture may also be used as concentration method 
to isolate and enrich NoVs from environmental (large 
volumes) and food (complex matrices) samples which 
may contain only low virus amounts. The proposed flow 
cytometry approach may serve as a prototype tool for the 
development of an immediate and sensitive method for 
routine HuNoV screening in biological, environmental and 
food samples and for confirmation and quantification dur-
ing outbreak investigations.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s12560- 021- 09494-w.
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